IP Library Patent Application 14325132
Patent Application
App. No. 14/325,132

PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/325,132
Abstract

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion which has been decellularized and at least one layer of chorion. Also described herein are methods for making and using the tissue grafts.

Claims (10)

1 . A laminated tissue graft comprising:

a first membrane comprising modified decellularized amnion, wherein the modified amnion comprises an exposed basement membrane;

a second membrane comprising cleaned and washed chorion membrane retaining a cellular component layered adjacent to the first membrane, said chorion membrane layered adjacent to said first membrane; and

optionally one or more additional membranes layered over the first or second membrane, wherein the one or more additional membranes is selected from the group consisting of amnion, decellularized amnion, chorion, decellularized chorion, allograft pericardium, allograft acellular dermis, amniotic membrane, Wharton's jelly, and combinations thereof;

wherein the laminated tissue graft is dehydrated.

2 . The laminated tissue graft of claim 1 , wherein one side of the first membrane is a decellularized fibroblast layer.

3 . The laminated tissue graft of claim 1 , wherein one side of the first membrane is an exposed compact layer.

4 . The laminated tissue graft of claim 1 , wherein one side of the first membrane is the other side of the basement membrane, wherein the other side of the basement membrane is exposed.

5 . (canceled)

6 . The laminated tissue graft of claim 1 , further comprising at least one component selected from the group consisting of a naturally occurring growth factor, a platelet concentrate, a bone marrow aspirate, stem cells, or an antibiotic.

Assignments (3)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2019
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: MIMEDX GROUP, INC.
Reel/Frame 048121/0835 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Oct 15, 2015
From: MIMEDX GROUP, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036872/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2014
From: KOOB, THOMAS J.; BROWN, REBECCAH J.C.; DEAN, DEBORAH L.; PETIT, PARKER
To: MIMEDX GROUP, INC.
Reel/Frame 034010/0340 →